pharmaphorum

MAY 14, 2021

Experts from ICON give us their views on the past, present and future of NICE’s standing on the world stage. Long headquartered in London, the EU drug regulator is now severed from the country both physically and systematically, with its base now in Amsterdam and the UK now assessing drugs through its own regulatory agency, MHRA.

Drug Pricing 59

Drug Pricing Documentation Pharmaceutical Companies Pharmaceutical Companies 59

Viseven

JANUARY 13, 2023

Evaluation of drug efficiency on a dedicated market is a complex process that requires HEOR experts to measure multiple indicators to understand the actual market value of the product. So what do exactly HEOR experts do for the pharmaceutical companies and what HEOR-collected data is used for? What is HEOR Data?

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Dosage Drug Pricing 40

Pharmaceutical Technology

FEBRUARY 7, 2023

An example is NICE’s Quality Adjusted Life Year score, used to price drugs in the UK. Some nations such as France base their decisions on the drug’s medical benefit and clinical added value versus existing therapies. Much of this refers to the individual evidence requirements of European HTAs and payers.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Inpatient Drug Pricing Packaging 52

PharmaShots

MAY 9, 2023

Sit back and relax, while the article unfolds before you, the magic model that is certain to revamp your company Achieving economic sustenance and ensuring smooth sailing even in unfavorable situations are two common dreams that every pharmaceutical company shares.

Pharmaceutical Companies 56

Pharmaceutical Companies Pharmaceutical Companies Drug Development Drug Pricing 56

STAT

MARCH 26, 2024

The evidence presented itself early this morning as the official mascots dashed about the grounds to bark about passersby, and a steady parade of driving machines could be seen from our window. Rise and shine, everyone, another busy day is on the way. All of which is to say that a cup of stimulation is in order.

Drug Pricing 264

Drug Pricing Insurance Coverage and Processing Diabetes Pharmaceutical Companies 264

STAT

SEPTEMBER 14, 2023

So join us as we hoist the ever-present cup of stimulation — our choice today is roasted coconut — and attack the fast-growing to-do list. Patent and Trademark Office coordinate efforts to prevent pharmaceutical companies from unfairly extending monopolies on their medicines.

Drug Pricing 274

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 274

Pharma Marketing Network

APRIL 1, 2025

Table of Contents: Understanding Pharma Tariffs Impacts on Branded Drug Marketing Adjusting Digital Advertising Strategies Strategic Recommendations for Pharma Marketers Conclusion FAQs Understanding Pharma Tariffs Pharma tariffs are taxes imposed by governments on imported pharmaceutical products.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 52

STAT

JANUARY 17, 2025

The winter doldrums may be upon us, but this may also present an opportunity to enjoy the great outdoors by taking a brisk walk. In its lawsuit , the company argued the U.S. We also hope to hold yet another listening party, where the rotation will likely include this , this , this , this and this. And what about you?

Drug Pricing 310

Drug Pricing Diabetes Hospitals Pharmaceutical Companies 310

Proxsys Rx

AUGUST 16, 2023

In the column, Hassell calls-attention to an earlier op-ed column published by The Hill as “yet another example of a drug company-focused view on the 340B Drug Pricing Program, couched in the language of reform.” “Its First, start with presenting drug company-funded research as if it is non-biased.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Hospitals Drug Pricing Pharmaceutical Companies 52

European Pharmaceutical Review

FEBRUARY 20, 2025

Impact on drug pricing and affordability Increased API costs may force some manufacturers to reduce output or exit the market entirely, reducing competition and potentially driving price inflation” Rising production costs due to tariffs could lead to higher drug prices, particularly in markets where pricing pressures are already a concern.

Drug Pricing 20

Drug Pricing Pharmaceutical Manufacturing Generic Medicine Hospitals 20